Overview Request Sample Pages Request Customization Download PDF
You are viewing: North America Bioinformatics Market analysis
Part of: Bioinformatics Market (Global)

The North America Bioinformatics Market was valued at $7876.8 Million in 2026 and projected to reach to $14624.3 Million by 2031, representing a compound annual growth rate of 13.2%. North America's bioinformatics market is positioned for sustained expansion through 2031, with the region's 13.2% CAGR outpacing global growth.

North America Bioinformatics Market (2026-2031) : Size and Share
logo-mobile
CAGR of
cagr-Chart
USD Million
MARKET SNAPSHOT
Market Size in USD 26.32 MN
Market Forecast in
CAGR
Forecast Period
Units Considered Value (USD MN)

North America Bioinformatics Market Trends and Insights

  • This growth trajectory reflects North America's leadership in genomic research, precision medicine adoption, and advanced computational infrastructure.
  • North America benefits from substantial investments in biotechnology R&D, a mature healthcare ecosystem, and strong regulatory frameworks that accelerate bioinformatics tool deployment across pharmaceutical, clinical diagnostics, and academic research sectors. The 13.2% compound annual growth rate in North America underscores the region's commitment to integrating artificial intelligence and machine learning into drug discovery and personalized medicine initiatives.
  • North America's bioinformatics expansion is driven by increasing demand for data analytics in clinical genomics, growing prevalence of chronic diseases requiring genetic insights, and collaboration between technology companies and healthcare institutions.
  • By 2031, North America is expected to maintain its position as a primary market for bioinformatics solutions, supported by continuous innovation and substantial capital allocation toward computational biology platforms..

Key Market Statistics

  • CAGR (2026-2031) 13.2% CAGR
  • Market Size, 2026 ~USD 7876.8 Million
  • Forecast, 2031 ~USD 14624.3 Million
  • Geography North America

North America Bioinformatics Market Overview

US Market Dominance :

The United States commands the North American bioinformatics market with $13,592.8 million in 2026, driven by leading pharmaceutical companies, academic research institutions, and advanced healthcare infrastructure supporting genomic sequencing and personalized medicine initiatives.

Precision Medicine Leadership :

North America leads global adoption of precision medicine and genomic-driven therapeutics, with substantial FDA approvals for companion diagnostics and biomarker-driven treatments accelerating bioinformatics tool deployment across clinical and research settings.

Robust R&D Investment :

The region benefits from significant venture capital funding, government grants (NIH, NSF), and corporate R&D spending in biotechnology, creating a fertile ecosystem for bioinformatics software, cloud platforms, and AI-driven analytical solutions.

Canadian Growth Momentum :

Canada's bioinformatics market valued at $1,031.5 million in 2026 reflects strong government support for life sciences, growing genomics research centers, and increasing adoption of computational biology in healthcare and agricultural biotechnology sectors.

North America Bioinformatics Market Dynamics

  • The US market leadership, combined with Canada's emerging capabilities, creates a unified North American hub for genomic innovation.
  • Drivers include increasing whole genome sequencing adoption, expansion of precision oncology programs, and integration of AI/machine learning in drug discovery pipelines. The region's mature healthcare infrastructure, regulatory clarity, and high healthcare spending support continued investment in bioinformatics platforms.
  • Consolidation among software vendors, cloud migration of genomic databases, and growing demand for real-world evidence analytics will further accelerate market penetration.
  • North America is expected to maintain its competitive advantage through technological innovation and strategic partnerships between biotech firms and healthcare providers..

Market Ecosystem

logo-mobile

BIOINFORMATICS MARKET: COMMERCIAL USE CASES ACROSS INDUSTRIES

COMPANY USE CASE DESCRIPTION BENEFITS
Provides bioinformatics solutions for genomic data analysis, next-generation sequencing (NGS) workflows, molecular diagnostics, and life science research. Its platforms support sequencing data interpretation, variant analysis, and clinical research applications. Faster genomic data analysis, improved accuracy in variant interpretation, streamlined NGS workflows, enhanced research productivity, and support for precision medicine development.
Offers integrated sequencing and bioinformatics platforms for analyzing large-scale genomic data. Its solutions support applications in oncology, inherited disease research, population genomics, and clinical diagnostics through advanced sequencing data analysis. Efficient management of complex genomic datasets, improved disease identification, faster biomarker discovery, enhanced clinical decision-making, and acceleration of personalized medicine.
Provides bioinformatics software and genomic analysis platforms for sample-to-insight workflows, molecular diagnostics, clinical research, and next-generation sequencing data interpretation. Simplified data analysis, improved workflow automation, reliable genomic insights, reduced analysis time, and enhanced support for molecular testing and precision healthcare.
Develops bioinformatics tools for genomics, transcriptomics, and molecular analysis, supporting applications such as microarray analysis, NGS data interpretation, and biomarker discovery in research and clinical settings. Improved data visualization and interpretation, increased research efficiency, accurate molecular profiling, faster discovery of biological insights, and optimized laboratory workflows.
Provides integrated bioinformatics solutions supporting clinical genomics, companion diagnostics, oncology research, and precision medicine. Its platforms enable genomic data analysis for targeted therapies and biomarker identification. Enhanced biomarker assessment, faster treatment decisions, improved diagnostic accuracy, optimized clinical workflows, and support for personalized medicine approaches.

Logos and trademarks shown above are the property of their respective owners. Their use here is for informational and illustrative purposes only.

Related Ecosystem

Healthcare It

Top Technologies
  • Computed Tomography (CT)
  • Machine Learning
  • Magnetic Resonance Imaging (MRI)
  • Natural Language Processing (NLP)
  • Predictive Analytics
Top Companies
  • CERNER CORPORATION
  • PHILIPS HEALTHCARE
  • Oracle Corporation
  • GE HealthCare Technologies Inc.
  • Siemens healthineers

    Pharmaceuticals

    Top Technologies
    • Bioreactors
    • Analytical Testing
    • Bioanalytical Testing Services
    • Cell Counters
    • Data Management Services
    Top Companies
    • Thermo Fisher Scientific Inc.
    • SANOFI
    • Merck KGaA
    • NOVARTIS
    • Pfizer Inc.

      Key Takeaways

      • North America's bioinformatics market will nearly double from $7.88B (2026) to $14.62B (2031), representing a 13.2% CAGR.
      • North America leads global bioinformatics adoption due to advanced healthcare infrastructure, significant R&D investment, and precision medicine initiatives.
      • North America's market growth is fueled by AI/ML integration in drug discovery, clinical genomics demand, and public-private research collaborations.
      • North America is positioned to maintain market leadership through 2031 with continuous innovation in computational biology and genomic data analytics.

      Bioinformatics Market Report Scope

      Report Metric Details
      Base Year 2026
      Fastest Growing Segment PRECISION MEDICINE (Use Case)
      Forecast Period 2026-2031
      Growth Rate CAGR of 13.1% from 2026 to 2031
      Largest Segment SOFTWARE (Offering)
      Market Size Base Year (Billions) ~USD 18.59 (2026)
      Revenue Forecast (Billions) ~USD 34.41 (2031)
      Segments Covered Offering, Type, Function, Use Case, Sector, End User

      North America Bioinformatics Market Report Segmentation

      6 segment dimensions are covered across the global market.

      By Offering

      • Services
      • Software

      By Type

      • Chemoinformatics Solutions
      • Cloud & Managed Bioinformatics
      • Cloud & Managed Services
      • Consulting & Custom Bioinformatics Development
      • Data Analysis & Interpretation
      • Database & Data Management
      • Drug Discovery & Target Identification
      • End-To-End Solutions
      • Gene Expression Analysis
      • Generalized Knowledge Management Tools
      • Genomics Solutions
      • Knowledge Management Tool
      • Metabolomics Solutions
      • Multi-Omics Solutions
      • Multiomics Solutions
      • Niche Point Solutions
      • Other Bioinformatics Services
      • Other Data Analysis Functions
      • Other End-To-End Solutions
      • Other Services
      • Proteomics Solutions
      • Sequence Analysis
      • Sequencing & Data Generation
      • Specialized Knowledge Management Tools
      • Transcriptomics Solutions
      • Variant Analysis

      By Function

      • Clinical Interpretation
      • Data Analysis
      • Data Visualization & Reporting
      • Multiomics Integration
      • Other Functions
      • Structural & Functional Analysis

      By Use Case

      • Biomarker Discovery
      • Clinical Diagnostics
      • Drug Discovery & Development
      • Other Use Cases
      • Precision Medicine
      • Research & Academic Applications

      By Sector

      • Animal Biotechnology
      • Environmental Biotechnology
      • Forensic Biotechnology
      • Medical Biotechnology
      • Other Sectors
      • Plant Biotechnology

      By End User

      • Academic & Research Institutes
      • Contract Research Organizations And Contract Development & Manufacturing Organizations
      • Government & Public Health Organizations
      • Hospitals & Clinical Diagnostic Laboratories
      • Other End Users
      • Pharmaceutical & Biotechnology Companies

      Target Audience

      • Bioinformatics Software Vendors : Evaluate North America's $7.9B market opportunity and identify expansion strategies, customer acquisition costs, and competitive positioning within the US and Canadian genomics software and analytics platform segments.
      • Pharmaceutical & Biotech Companies : Assess bioinformatics infrastructure investments required for precision medicine programs, drug discovery acceleration, and clinical trial optimization across North American R&D operations and commercial divisions.
      • Healthcare Providers & Hospital Systems : Understand adoption trends for genomic testing platforms, clinical decision support systems, and personalized medicine workflows to enhance diagnostic capabilities and patient outcomes in North American healthcare settings.
      • Investment & Private Equity Firms : Identify high-growth bioinformatics subsectors, emerging technology leaders, and consolidation opportunities within North America's $14.6B projected 2031 market for portfolio development and exit strategies.
      • Academic & Research Institutions : Benchmark genomic research infrastructure investments, identify funding opportunities, and align computational biology programs with North America's precision medicine initiatives and industry collaboration trends.

      Key Companies in the North America Bioinformatics Market

      CompanyHQOwnershipStrongest segments
      BECKMAN COULTERUnited StatesPrivate CompanyBioinformatics Software (Genomics, Multiomics, Proteomics),Bioinformatics Services (Analysis, Sequencing, Genomic Services),
      WUXI APPTECChinaPublic CompanyChemical Business,Testing Services,Biological Services,
      DANAHER CORPORATIONUnited StatesPublic CompanyDiagnostics,Life Sciences (Excl. Biotechnology),Biotechnology,
      THERMO FISHER SCIENTIFIC INC.United StatesPublic CompanyLife Sciences Solutions,Analytical Instruments,Specialty Diagnostics,
      ILLUMINA, INC.United StatesPublic CompanySequencing and array-based instruments,Consumables (reagents, flow cells, library preparation, WGS and targeted kits),Services (whole-genome sequencing, genotyping, NIPT, product support, informatics services),
      QIAGEN N.V.NetherlandsPublic CompanyBioinformatics software (genomics, multiomics, proteomics),Bioinformatics-linked services (analysis, sequencing, interpretation),Non-bioinformatics consumables and instruments,
      AGILENT TECHNOLOGIES, INC.United StatesPublic CompanyAgilent CrossLab,Life Sciences and Diagnostics Markets,Applied Markets,
      REVVITY, INC.United StatesPublic CompanyLife Sciences,Diagnostics,
      EUROFINS SCIENTIFICLuxembourgPublic CompanyBioinformatics-linked genomics and multiomics services,Non-informatics analytical testing (food, environment, consumer, other),
      BGI GENOMICSChinaPublic CompanySequencing and Bioinformatics Services,Clinical Testing and Precision Medicine Solutions,Mass Spectrometry and Multi-omics (Proteomics, Metabolomics, Multi-omics Integration),
      WATERS CORPORATIONUnited StatesPublic CompanyWaters Segment (LC-MS systems, consumables, and software),Materials Sciences Division (thermal analysis, rheometry, calorimetry),
      OXFORD NANOPORE TECHNOLOGIES PLCUnited KingdomPublic CompanySequencing instruments (MinION, GridION, PromethION),Consumables and flow cells,Software and bioinformatics services,
      10X GENOMICSUnited StatesPublic CompanySingle-cell and spatial instruments (Chromium, Chromium X Series, Visium, Xenium Analyzer, CytAssist),Consumables and reagents (microfluidic chips, slides, kits including QuantumScale),Bioinformatics software and analysis services (Cell Ranger, Loupe Browser, Xenium Explorer, associated analysis support),
      PACBIOUnited StatesPublic CompanySequencing instruments (Revio, Vega, Sequel, Onso),Consumables (SMRT cells, SMRTbell prep kits, binding and sequencing kits),Software and services (bioinformatics analysis, sequencing services, collaborations),
      SIEMENS AGGermanyPublic CompanyIndustrial Businesses (IB) - Siemens Healthineers,Industrial Businesses (IB) - Smart Infrastructure,Industrial Businesses (IB) - Digital Industries,
      SOPHIA GENETICSSwitzerlandPublic CompanySOPHiA DDM Software Platform (Genomics, Multiomics, Proteomics),Services (Analysis Support, Sequencing-Linked Informatics, Implementation),

      BECKMAN COULTER

      Beckman Coulter is a private American company founded in 1935 that employs 11,900 people. The company operates in the life sciences and diagnostics sector.

      WUXI APPTEC

      WuXi AppTec is a public Chinese company founded in 2000 with 35,584 employees. The company provides pharmaceutical and biotechnology research and development services.

      DANAHER CORPORATION

      Danaher Corporation is a public American company founded in 1969 with 59,000 employees. The company operates across multiple sectors including life sciences, diagnostics, and environmental solutions.

      THERMO FISHER SCIENTIFIC INC.

      Thermo Fisher Scientific Inc. is a public American company founded in 1956 with 125,000 employees. The company is a leading provider of laboratory equipment, reagents, and services for life sciences research and diagnostics.

      ILLUMINA, INC.

      Illumina, Inc. is a public American company founded in 1998 with 8,625 employees. The company specializes in DNA sequencing and genetic analysis technologies.

      QIAGEN N.V.

      QIAGEN N.V. is a public Dutch company founded in 1984 with 5,500 employees. The company develops and manufactures molecular diagnostics and life sciences products.

      AGILENT TECHNOLOGIES, INC.

      Agilent Technologies, Inc. is a public American company founded in 1999 with 18,000 employees. The company provides analytical instruments, software, and services for life sciences and diagnostics.

      REVVITY, INC.

      Revvity, Inc. is a public American company founded in 1937 with 11,000 employees. The company provides analytical instruments and life sciences solutions.

      EUROFINS SCIENTIFIC

      Eurofins Scientific is a public Luxembourg-based company founded in 1987 with 65,694 employees. The company operates a network of laboratories providing testing and analytical services across multiple industries.

      BGI GENOMICS

      BGI Genomics is a public Chinese company founded in 1999 with 3,580 employees. The company specializes in genomic sequencing and genetic analysis services.

      WATERS CORPORATION

      Waters Corporation is a public American company founded in 1958 with 7,900 employees. The company manufactures analytical instruments and software for laboratory testing and research.

      OXFORD NANOPORE TECHNOLOGIES PLC

      Oxford Nanopore Technologies PLC is a public British company founded in 2005 with 1,316 employees. The company develops nanopore-based DNA and RNA sequencing technologies.

      10X GENOMICS

      10X Genomics is a public American company founded in 2012 with 1,178 employees. The company develops single-cell and spatial genomics solutions for research and diagnostics.

      PACBIO

      PacBio is a public American company founded in 2000 with 485 employees. The company develops long-read DNA sequencing technologies and systems.

      SIEMENS AG

      Siemens AG is a public German company founded in 1847 with 317,000 employees. The company operates across multiple sectors including industrial automation, energy, healthcare, and infrastructure.

      SOPHIA GENETICS

      Sophia Genetics is a public Swiss company founded in 2011 with 415 employees. The company provides AI-powered genomic analysis and interpretation software for clinical diagnostics.

      North America vs. other regions

      HowNorth America compares to the other 3 regional blocs covered in this market.

      Europe
      ~USD 10071.8 Million · 12.6% wtd CAGR ·
      Asia Pacific
      ~USD 7120.8 Million · 14.2% wtd CAGR ·
      Latin America
      ~USD 1635.8 Million · 11.9% wtd CAGR ·
      Middle East & Africa
      ~USD 960.4 Million · 10.2% wtd CAGR ·

      Countries within North America - compare and drill down

      Country2025 size (native)
      USUSD 13592.8 Million
      CanadaUSD 1031.5 Million

      Country market size visualization

      US
      USD 13592.8 Million
      Canada
      USD 1031.5 Million

      Reasons to Buy this Report

      • Market Size & Growth Validation : Comprehensive data on North America's $7.9B market (2026) expanding to $14.6B (2031) at 13.2% CAGR, with country-level breakdown for US ($13.6B) and Canada ($1.0B) enabling precise investment and expansion planning.
      • Competitive Landscape Intelligence : Understand market dynamics specific to North America's mature bioinformatics ecosystem, including vendor positioning, technology adoption rates, and regional competitive advantages in precision medicine and genomic research applications.
      • Strategic Market Entry Guidance : Identify high-growth segments within North America's bioinformatics sector, including clinical genomics, drug discovery analytics, and agricultural biotechnology, with actionable insights for market penetration and partnership opportunities.
      • Investment Decision Support : Access detailed forecasts and growth drivers specific to North America, enabling venture capitalists, private equity firms, and corporate strategists to make informed funding and acquisition decisions in the region's thriving biotech ecosystem.
      • Regulatory & Operational Context : Gain region-specific insights into FDA approval trends, healthcare reimbursement models, and data privacy regulations (HIPAA) that directly impact bioinformatics solution adoption and commercial viability in North American markets.

      Frequently asked questions

      What is the projected size of North America's bioinformatics market by 2031?

      North America's bioinformatics market is projected to reach $14,624.3 million by 2031, growing from $7,876.8 million in 2026.

      What is the CAGR for North America's bioinformatics market?

      North America's bioinformatics market is expected to grow at a compound annual growth rate of 13.2% between 2026 and 2031.

      What factors are driving growth in North America's bioinformatics market?

      North America's bioinformatics growth is driven by precision medicine adoption, AI/ML integration in drug discovery, clinical genomics demand, substantial R&D investments, and collaborations between technology and healthcare sectors.

      How does North America's bioinformatics market compare to global trends?

      North America's 13.2% CAGR slightly exceeds the global average of 13.1%, reflecting the region's advanced infrastructure, regulatory support, and leadership in genomic research and personalized medicine.

      Which sectors in North America are driving bioinformatics adoption?

      North America's bioinformatics adoption is strongest in pharmaceutical R&D, clinical diagnostics, academic research institutions, and precision medicine programs focused on chronic disease management.

      RESEARCH METHODOLOGY

      This research study involved the extensive use of both primary and secondary sources. It analyzed various factors affecting the industry to identify segmentation types, industry trends, key players, the competitive landscape of market players, and key market dynamics such as drivers, opportunities, challenges, restraints, and key player strategies.

      Secondary Research

      This research study extensively used secondary sources, including directories, databases such as Dun & Bradstreet, Bloomberg Businessweek, and Factiva, as well as white papers, annual reports, and companies' house documents. The secondary research aimed to gather and analyze information for a comprehensive, commercially focused study of the bioinformatics market, covering technical aspects and market dynamics. It also helped identify key players, market classifications, industry trends, geographic markets, and significant market developments. Additionally, a database of prominent industry leaders was compiled through secondary research.

      Primary Research

      In the primary research process, various supply-side and demand-side sources were interviewed to gather qualitative and quantitative information for this report. Primary supply-side sources included industry experts such as CEOs, VPs, managing directors, marketing and sales heads/directors, marketing managers, regional/area sales managers, and bioinformatics scientists. Primary demand-side sources included personnel from pharmaceutical and biotechnology companies, hospitals, diagnostic laboratories, and academic and research institutes.

      A breakdown of the primary respondents is provided below:

      Bioinformatics Market Size, and Share

      *Others include sales managers, marketing managers, and product managers.
      Note: Tiers are defined based on a company’s total revenue, as of 2025: Tier 1 = >USD 1 billion, Tier 2 = USD 500 million to USD 1 billion, and Tier 3 = <USD 500 million.

      To know about the assumptions considered for the study, download the pdf brochure

      Market Size Estimation

      The total size of the bioinformatics market was determined after data triangulation using the two approaches outlined below. After each approach was completed, the weighted average of the two approaches was calculated based on the level of assumptions used in each approach.

      Bioinformatics Market : Top-Down and Bottom-Up Approach

      Bioinformatics Market Top Down and Bottom Up Approach

      Data Triangulation

      The size of the bioinformatics market was estimated through segmental extrapolation using the bottom-up approach. The methodology is as follows:

      • Revenue information of individual companies was gathered from public sources and databases.
      • The share of leading players in the bioinformatics market was obtained from secondary sources to the extent available. In certain cases, shares of bioinformatics businesses have been ascertained after a detailed analysis of various parameters, including product portfolios, market positioning, selling price, and geographic reach and strength. 
      • Individual shares or revenue estimates were validated through interviews with experts.
      • The total revenue in the bioinformatics market was determined by extrapolating the market share data of major companies.

      Market Definition

      Bioinformatics is the application of computer technology to the management and analysis of biological data. It encompasses the storage, analysis, and dissemination of biological data. Bioinformatics uses computer programs for a variety of applications, including determining gene and protein functions, establishing evolutionary relationships, and predicting the three-dimensional shapes of proteins.

      Key Stakeholders

      • Bioinformatics software and service providers
      • Academic & research institutes
      • Clinical & diagnostic laboratories
      • Hospitals & healthcare providers
      • Contract research organizations (CROs)
      • Distributors and suppliers of bioinformatics software and services
      • Pharmaceutical & biotechnology companies
      • Market research and consulting firms
      • Venture capitalists

      Report Objectives

      • To define, describe, and forecast the bioinformatics market based on offering, function, use case, sector, end user, and region
      • To provide detailed information regarding the major factors influencing the market growth (such as drivers, restraints, opportunities, and challenges)
      • To analyze the micromarkets1 with respect to individual growth trends, prospects, and contributions to the overall bioinformatics market
      • To analyze opportunities for stakeholders and provide details of the competitive landscape for market leaders
      • To forecast the size of the market segments with respect to five main regions, namely, North America, Europe, the Asia Pacific, Latin America, the Middle East & Africa.
      • To profile the key players and analyze their market share and core competencies2
      • To track and analyze competitive developments such as product launches & approvals, partnerships, agreements, and collaborations in the overall bioinformatics market
      • To benchmark players within the market using the proprietary "Competitive Leadership Mapping" framework, which analyzes market players on various parameters within the broad categories of business and product strategy.

      Available customizations:

      With the given market data, MarketsandMarkets offers customizations as per your company’s specific needs. The following customization options are available for the report:

      • Company Information
      • Detailed analysis and profiling of additional market players (up to 5)

      Product Analysis

      • Further breakdown of the Rest of Asia Pacific market into Taiwan, New Zealand, Thailand, Singapore, Malaysia, and other countries
      • Further breakdown of the Rest of Europe bioinformatics market into Russia, Austria, Finland, Turkey, Norway, Poland, Portugal, Romania, Denmark, and other countries

      Get the Full Bioinformatics Market Report

      Full forecast, segment splits, and company analysis for all Bioinformatics Market.

      Download Sample Pages Buy Report

      METHODOLOGY

      Need a Tailored Report?

      Customize this report to your needs

      Get 10% FREE Customization

      Customize This Report
      Fact checked
      Cite this Research
      DMCA.com Protection Status